Cargando…
Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing
BACKGROUND: Colposcopy was referred in cases with severe abnormalities in co-testing. Although p16/Ki67 dual staining reduced the referral rate, its sensitivity and specificity need to be enhanced. METHODS: The expressions of p16, Ki-67, SMAD3, YAP1, RELA were evaluated in the colposcopy referral po...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989978/ https://www.ncbi.nlm.nih.gov/pubmed/33776454 http://dx.doi.org/10.2147/OTT.S300269 |
_version_ | 1783668998643122176 |
---|---|
author | Huo, Xiao Sun, Hengzi Cao, Dongyan Yang, Jiaxin Peng, Peng Kong, Linghua Chen, Fei Shen, Keng Li, Shuhong |
author_facet | Huo, Xiao Sun, Hengzi Cao, Dongyan Yang, Jiaxin Peng, Peng Kong, Linghua Chen, Fei Shen, Keng Li, Shuhong |
author_sort | Huo, Xiao |
collection | PubMed |
description | BACKGROUND: Colposcopy was referred in cases with severe abnormalities in co-testing. Although p16/Ki67 dual staining reduced the referral rate, its sensitivity and specificity need to be enhanced. METHODS: The expressions of p16, Ki-67, SMAD3, YAP1, RELA were evaluated in the colposcopy referral population. The inclusion criteria included 30–60 years and diagnosed with HPV16/18-positive, other HR-HPV-positive with ASCUS, LSIL, AGC (atypical glandular cell) in co-testing. Colposcopies, endocervical curettages of cervical biopsies were also collected. Cases were excluded if there were no biopsies, if the interval between a cervical screening test and biopsies was more than 6 months, or if insufficient tissue was available as a formalin-fixed paraffin-embedded block. The pathology was independently reviewed by two pathologists. Discrepant interpretations were adjudicated by a third pathologist. RESULTS: In total, 1194 of 1273 cases who were referred to colposcopy were evaluated in the present study. The sensitivity and specificity of p16+ combined with Ki-67+ for predicting CIN2+ were 62.1% and 89.5%, respectively. p16+ combined with YAP1+ and/or RELA+ provided a sensitivity and specificity of 70.9% and 89.5%, respectively, while 72.8% and 86.4% were achieved by p16+ combined with YAP1+ and/or SMAD3+ and/or RELA+. In HPV16/18+ and LSIL subgroups, the sensitivity and specificity of p16+ combined with Ki-67+ for predicting CIN2+ were 67.7% and 87.6%, respectively, for the former group and 58.6%, 88.8%, respectively, for the latter group. p16+, YAP1+/RELA+ showed a better performance for predicting CIN2+ with a better sensitivity and considerable specificity in the other HPV+ combined with ASCUS group than were achieved by p16+ combined with Ki-67+. RELA+ and the combination of p16 and RELA/YAP1 also provided the Max AUC area. CONCLUSION: Our study shows that RELA and the combination of p16 and RELA/YAP1 achieved better sensitivity and specificity for detecting morphologically CIN2+ lesions. |
format | Online Article Text |
id | pubmed-7989978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-79899782021-03-25 Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing Huo, Xiao Sun, Hengzi Cao, Dongyan Yang, Jiaxin Peng, Peng Kong, Linghua Chen, Fei Shen, Keng Li, Shuhong Onco Targets Ther Original Research BACKGROUND: Colposcopy was referred in cases with severe abnormalities in co-testing. Although p16/Ki67 dual staining reduced the referral rate, its sensitivity and specificity need to be enhanced. METHODS: The expressions of p16, Ki-67, SMAD3, YAP1, RELA were evaluated in the colposcopy referral population. The inclusion criteria included 30–60 years and diagnosed with HPV16/18-positive, other HR-HPV-positive with ASCUS, LSIL, AGC (atypical glandular cell) in co-testing. Colposcopies, endocervical curettages of cervical biopsies were also collected. Cases were excluded if there were no biopsies, if the interval between a cervical screening test and biopsies was more than 6 months, or if insufficient tissue was available as a formalin-fixed paraffin-embedded block. The pathology was independently reviewed by two pathologists. Discrepant interpretations were adjudicated by a third pathologist. RESULTS: In total, 1194 of 1273 cases who were referred to colposcopy were evaluated in the present study. The sensitivity and specificity of p16+ combined with Ki-67+ for predicting CIN2+ were 62.1% and 89.5%, respectively. p16+ combined with YAP1+ and/or RELA+ provided a sensitivity and specificity of 70.9% and 89.5%, respectively, while 72.8% and 86.4% were achieved by p16+ combined with YAP1+ and/or SMAD3+ and/or RELA+. In HPV16/18+ and LSIL subgroups, the sensitivity and specificity of p16+ combined with Ki-67+ for predicting CIN2+ were 67.7% and 87.6%, respectively, for the former group and 58.6%, 88.8%, respectively, for the latter group. p16+, YAP1+/RELA+ showed a better performance for predicting CIN2+ with a better sensitivity and considerable specificity in the other HPV+ combined with ASCUS group than were achieved by p16+ combined with Ki-67+. RELA+ and the combination of p16 and RELA/YAP1 also provided the Max AUC area. CONCLUSION: Our study shows that RELA and the combination of p16 and RELA/YAP1 achieved better sensitivity and specificity for detecting morphologically CIN2+ lesions. Dove 2021-03-19 /pmc/articles/PMC7989978/ /pubmed/33776454 http://dx.doi.org/10.2147/OTT.S300269 Text en © 2021 Huo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Huo, Xiao Sun, Hengzi Cao, Dongyan Yang, Jiaxin Peng, Peng Kong, Linghua Chen, Fei Shen, Keng Li, Shuhong Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title | Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title_full | Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title_fullStr | Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title_full_unstemmed | Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title_short | Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing |
title_sort | evaluation of cervical high-grade squamous intraepithelial lesions-correlated markers as triage strategy for colposcopy after co-testing |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989978/ https://www.ncbi.nlm.nih.gov/pubmed/33776454 http://dx.doi.org/10.2147/OTT.S300269 |
work_keys_str_mv | AT huoxiao evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT sunhengzi evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT caodongyan evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT yangjiaxin evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT pengpeng evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT konglinghua evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT chenfei evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT shenkeng evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting AT lishuhong evaluationofcervicalhighgradesquamousintraepitheliallesionscorrelatedmarkersastriagestrategyforcolposcopyaftercotesting |